CRISPR AND CAS GENE MARKET ANALYSIS

Crispr and Cas Gene Market, By Product Type (Vector-based Cas, DNA-free Cas, and Others), By Application (Genome Engineering, Disease Models, Functional Genomics, Knockdown/Activation, and Others), By End User (Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Crispr and Cas Gene Market: Key Developments

On November 2, 2020, PerkinElmer, a company headquarted in U.S. acquired cell engineering specialist, Horizon Discovery Group for approximately US$ 383 million. Horizon Discovery Group is based in the U.K. about 400 employees worldwide with offices in the U.S. and Japan. They specialize in genetic base editing technologies for living cell models by way of CRISPR reagents, in addition to gene modulation products using RNA interference methods.
On April 6, 2020, GlaxoSmithKline plc, a pharmaceutical company, and Vir Biotechnology, Inc., a biotechnology company, headquartered in California, U.S. announced a agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The companies will leverage GSK’s expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to find anti-coronavirus compounds that target cellular host genes.